# Upgraded Molecular Testing Platforms Roche Diagnostics Debuts New Cobas 6800 and 8800 Systems By Kalin Ned | Published 2025-12-16 | Tech Source: Trend Hunter, https://www.trendhunter.com/trends/molecular-testing-platform References: [finance.yahoo](https://finance.yahoo.com/news/roche-announces-u-launch-next-133000931.html)  Roche Diagnostics, a leading biotechnology and diagnostics company, has introduced an upgraded version of its widely used molecular testing platforms — the cobas 6800 and 8800 systems — with new software. This product innovation is designated as version 2.0 and version 2.0.1 for the software. It is now available in the U.S. following regulatory clearance. [Roche Diagnostics'](https://www.trendhunter.com/trends/respiratory-test) upgrade to its molecular testing platforms is engineered to significantly augment the operational capacity of clinical laboratories. Key enhancements include a substantial increase in the variety of diagnostic tests that can be processed in a single automated run and the introduction of features that allow for the prioritization of urgent samples within the workflow. The system also boasts the ability to process both [FDA](https://www.trendhunter.com/trends/covidflu-test)-approved diagnostic tests and laboratory-developed tests concurrently, which aims to simplify complex laboratory logistics. Image Credit: Roche Diagnostics ## Trend Insights (Trend Hunter) - Score: 5.9/10 - Popularity: 55% | Activity: 64% | Freshness: 58% - Audience gender: 50% men, 50% women - Primary generations: Millennial, Gen X - Top markets: North America ## Categories [Trend Hunter](https://www.trendhunter.com/trends) > [Tech](https://www.trendhunter.com/tech) > [Gadgets](https://www.trendhunter.com/gadgets) ## Key Themes ### What's Driving This Trend - **Enhanced Laboratory Automation:** The integration of upgraded software in testing platforms is transforming laboratory efficiency by allowing for the simultaneous processing of multiple tests and prioritizing urgent samples. - **Concurrent Test Processing:** The capability to process FDA-approved diagnostics alongside laboratory-developed tests streamlines operations, reducing delays and complexities in clinical settings. - **Operational Capacity Expansion:** Advancements in molecular testing platforms significantly boost the operational throughput of clinical laboratories, driving a shift towards more dynamic and responsive diagnostic processes. ### Who This Affects Most - **Biotechnology:** The biotechnology sector is experiencing disruptive growth with innovations in diagnostic testing platforms enhancing the precision and speed of medical testing. - **Healthcare IT:** Healthcare IT is evolving with new software capabilities that improve diagnostic workflows, facilitating faster and more accurate clinical decision-making. - **Clinical Laboratories:** Operational improvements in clinical laboratories are being driven by advancements in automated testing systems, optimizing resource use and test management. ## Related on Trend Hunter - [Beverage-Focused Molecular Testing Systems](https://www.trendhunter.com/trends/molecular-testing.md) - [Digital Pathology Platforms](https://www.trendhunter.com/trends/digital-pathology-platform.md) - [Technologically Advanced Respiratory Tests](https://www.trendhunter.com/trends/respiratory-test.md) - [Automated Pcr Testing Systems](https://www.trendhunter.com/trends/automated-pcr-testing-system.md) - [Mobile X-Ray Units](https://www.trendhunter.com/trends/mobile-xray-unit.md) - [Respiratory Rapid Diagnosis Tools](https://www.trendhunter.com/trends/rapid-diagnosis-tool.md) - [Accelerated Clinical Trial Tools](https://www.trendhunter.com/trends/clinical-acceleration.md) - [Molecular Diagnostic Tools](https://www.trendhunter.com/trends/covidflu-test.md) - [Award-Winning Blood-Based Diagnostic Platforms](https://www.trendhunter.com/trends/bloodbased-diagnostic-platform.md)